Von Willebrand factor and autoantibodies against oxidized LDL in hemodialysis patients treated with vitamin E-modified dialyzers

International Journal of Artificial Organs

Volumn 27, Issue 3, 2004, Pages 214-221

  Bufano, Giuseppe ^a,e   Usberti, M ^b   Mandolfo, S ^c   Malberti, F ^a   Piroddi, M ^d   Galli, F ^d  

^a CREMONA HOSPITAL   (Italy)

^b Manerbio Hospital   (Italy)

^c Lodi Hospital   (Italy)

^d UNIVERSITY OF PERUGIA   (Italy)

^e NONE   (Italy)

Author keywords

Atherosclerosis; Hemodialysis; Vitamin E; von Willebrand factor

Indexed keywords

DIALYSIS; DISEASES; ENDOTHELIAL CELLS; HEMODIALYZERS; PATIENT MONITORING; PATIENT TREATMENT;

AUTOANTIBODIES; ENDOTHELIAL DAMAGE; HAEMODIALYSIS; HEMODIALYSIS PATIENT; NATURAL ANTIOXIDANTS; OXIDANT STRESS; PLASMA LEVELS; THROMBOMODULIN; VITAMIN-E; VON WILLEBRAND FACTOR;

GLYCOPROTEINS;

ALPHA TOCOPHEROL; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; AUTOANTIBODY; BIOCHEMICAL MARKER; CALCITRIOL; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; RECOMBINANT ERYTHROPOIETIN; THROMBOMODULIN; VON WILLEBRAND FACTOR;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIALYSIS MEMBRANE; ENDOTHELIUM CELL; ENDOTHELIUM LESION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INTERMETHOD COMPARISON; MATERIAL COATING; OXIDATIVE STRESS; PATHOGENESIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; VITAMIN BLOOD LEVEL;

EID: 2342483695     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880402700308     Document Type: Article

References (31)

1. Levey AS, Eknoyan G. Cardiovascular disease in chronic renal disease. Nephrol Dial Transplant 1999; 14: 828-33.
2. Weissberg PL, Bennett MR. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 1928-9.
3. Galle J, Heinloth A, Wanner C, Heermeier K. Dual effect of oxidized LDL on cell cycle in human endothelial cells through oxidative stress. Kidney Int 2001; 59 (suppl 78): S120-3.
4. Clermont G, Lecour S, Lahet J, et al. Alteration in plasma antioxidant capacities in chronic renal failure and hemodialysis patients: a possible explanation for the increased cardiovascular risk in these patients. Cardiovasc Res 2000; 47: 618-23.
5. Galli F, Canestrari F, Bellomo G. Physiopathology of the oxidative stress and its implication in uremia and dialysis. Contrib Nephrol 1999; 127: 1-31.
6. Maggi E, Bellazzi R, Gazo A, et al. Autoantibodies against oxidatively-modified LDL in uremic patients undergoing dialysis. Kidney Int 1994; 46: 869-76.
7. Tomura S, Nakamura Y, Deguchi F, et al. Plasma von Villebrand factor and Thrombomodulin as markers of vascular disorders in patients undergoing regular hemodialysis therapy. Thromb Res 1990; 58; 413-19.
8. Holvoet P, Donck J, Landeloos M, Brouwers E, Luijtens K, Arnout J, Lesaffre E, Vanrenterghem Y, Collen D. Correlation between oxidized low density liporpoteins and von Willebrand factor in chronic renal failure. Thromb Haemost 1996; 76: 663-9.
9. Gris J-C, Branger B, Vécina F, Al Sabadani B, Fourcade J, Schvod J-F. Increased cardiovascular risk factors and features of endothelial activation and dysfunction in dialyzed uremic patients. Kidney Int 1994; 46: 807-13.
10. Miyazaki H, Matsuoka H, Itabe H,et al. Hemodialysis impairs endothelial function via oxidative stress: effects of vitamin E-coated dialyzer. Circulation 2000; 101: 1002-6.
11. Mune M, Yukawa S, Kishino M, et al. Effect of vitamin E on lipid metabolism and atherosclerosis in ESRD patients. Kidney Int 1999; 56 (suppl): S126-9.
12. Boaz M, Smetana S, Green MS. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): Randomised placebo-controlled. Lancet 2000; 356: 1213-18.
13. Wang X, Quinn PJ. Vitamin E and its function in membranes. Prog Lipid Res 1999; 38: 309-36.
14. Galli F, Canestrari F, Buoncristiani U. Biological effects of oxidative stress in hemodialysis: The possible roles of the vitamin E. Blood Purif 1999; 17: 79-94.
15. Bonnefont-Rousselot D, Lehmann E, Jaudon M-C, Delattre J, Perrone B, Rechke J-P. Blood oxidative stress and lipoprotein oxidizability in haemodialysis patients: Effect of the use of a vitamin E-coated dialysis membrane. Nephrol Dial Transplant 2000; 15: 2020-8.
16. Galli F, Ferraro B, Varga Z, Canestrari F, Floridi A, Buoncristiani U. Vitamin E, lipid profile and oxidation in hemodialysis patients. Kidney Int 2001; 59 (suppl 78): S148-54.
17. Panzetta O, Cominacci L, Garbin U, et al. Increased susceptibility of LDL to in vitro oxidation in patients on maintenance hemodialysis: effects of fish oil and Vitamin E administration. Clin Nephrol 1995; 44: 303-9.
18. Galli F, Ronco C. Oxidant stress in hemodialysis. Nephron 2000; 84: 1-5.
19. Galli F. Vitamin E-modified dialyzers. Contrib Nephrol 2002; 137: 1-11.
20. Satoh M, Yamasaki Y, Nagake Y, et al. H. Oxidative stress is reduced by the long-term use of vitamin E-coated dialysis filters. Kidney Int 2001; 59: 1943-50.
21. Clermont G, Lecour S, Cabanne J, et al. Vitamin E-coated dialyzer reduces oxidative stress in hemodialysis patients. Free Radic Biol Med 2001; 31: 233-41.
22. Erkkila AT, Narvanen O, Lehto S, Uusitupa MI, Yla-Herttuala S. Autoantibodies against oxidized low-density lipoprotein and cardiolipin in patients with coronary heart disease. Arterioscler Thromb Vasc Biol 2000; 20: 204-9.
23. Tsimikas S, Palinski W, Witzum JL. Circulating autoantibodies to oxidized LDL correlate with arterial accumulation and depletion of oxidized LDL in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 2001; 21: 95.
24. Wratten ML, Tetta C, Ursini F, Sevanian A. Oxidant stress in hemodialysis: prevention and treatment strategies. Kidney Int 2001; 59 (suppl): S32-6.
25. Hulthe J, Bokemark L, Fagerberg B. Antibodies to oxidized LDL in relation to intima-media thickness in carotid and femoral arteries in 58-year-old subjectively clinically healthy men. Arterioscler Thromb Vasc Biol 2001; 21: 101.
26. Huang N, Lineberger B, Steiner M. Alpha tocopherol, a potent modulator on endothelial cell function. Thromb Res 1988; 50: 547-57.
27. Jaffe EA. Vascular function in homeostasis. In: Beutler E, et al, eds. Williams hematology, 5th ed. New York-London: McGraw-Hill, Inc. 1995; 125: 1261-76.
28. Tani N, Hada K, Kitami A,Nakano M, Tkahashi H, Ito I, Shibata A. Effects of acetyl salycilic acid and cilostazol administration on serum thrombomodulin concentration in diabetic patients. Thrombosis Res 1993; 69: 153-8.
29. Hirokawa K, Aoki N. Up-regulation of thrombomodulin in human umbilical vein andothelial cells in vitro. J Biochem 1990; 108: 839-45.
30. Schiecke G, Gwinner W, Radermaker J, Bahlmann J, Lonnemann G. Long-term effects of vitamin E bonded dialysis membrane on mononuclear cell activation, malondialdehyde generation and endothelial function in ESDR patients. Contrib Nephrol 1999; 127: 244-51.
31. Shimazu T, Ominato M, Yasuda T, et al. Effect of a vitamin E bonded dialysis membrane on neutrophil superoxide anion radical production. Kidney Int 2001; 59 (suppl 78): S137-43.